12
Participants
Start Date
January 1, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
Cell-free Stem Cell-derived Extract Formulation (CCM)
Intraarticular injection
Lead Sponsor
General Therapeutics
INDUSTRY